SCHEMBL2524893

SCHEMBL2524893

COC(C)OP(=O)(O)OC(C)OC

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
CA9 Q16790 1/20 0.33
CTSA P10619 1/20 0.32
ACHE P22303 1/20 0.32
LAP3 P28838 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2598057 0.85 LMNA (0.42) MMP1MMP2
SCHEMBL1514201 0.83
SCHEMBL2598174 0.82 METAP1 (0.32)
Phosphoric Acid SCHEMBL26662213 0.79 CA2 (0.38) CA2CA12CA1MMP1MMP2
SCHEMBL7731451 0.79
Phosphoramidic Acid SCHEMBL220946 0.77 LAP3 (0.32) CA2CA12CA1MMP1MMP2
SCHEMBL2048661 0.77 CTSA (0.35) CTSAACHE
SCHEMBL4951275 0.74
SCHEMBL31116709 0.74 CA2 (0.32) CA2
SCHEMBL11822837 0.74 CTSA (0.33) CTSAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2337805-B2 POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE MITSUI CHEMICALS INC (JP) 2025-06-18 EP disclosed
EP-3129353-B1 METHOD FOR MANUFACTURING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE COVESTRO DEUTSCHLAND AG (DE) 2024-02-28 EP disclosed
CN-112088043-B Compounds for coordination to metals, compositions containing such compounds and methods of catalyzing reactions PPG工业俄亥俄公司 2023-06-27 CN disclosed
WO-2023106258-A1 POLYMERIZABLE COMPOSITION FOR MANUFACTURING MOLDED ARTICLE, MOLDED ARTICLE AND MANUFACTURING METHOD THEREOF MITSUI CHEMICALS, INC. (JP) 2023-06-15 WO disclosed
US-11618756-B2 Compounds for coordinating with a metal, compositions containing such compounds, and methods of catalyzing reactions PPG INDUSTRIES OHIO, INC. (US) 2023-04-04 US disclosed
EP-2571914-B1 A POLYMERIZATION CATALYST FOR POLYTHIOURETHANES, POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC POLYTHIOURETHANE GLASS WITH A HIGH REFRACTIVE INDEX MITSUI CHEMICALS INC (JP) 2021-12-29 EP disclosed
US-20210079009-A1 Compounds for Coordinating with a Metal, Compositions Containing Such Compounds, and Methods of Catalyzing Reactions PPG INDUSTRIES OHIO, INC. (US) 2021-03-18 US disclosed
EP-3762143-A1 COMPOUNDS FOR COORDINATING WITH A METAL, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF CATALYZING REACTIONS PPG Industries Ohio Inc. (US) 2021-01-13 EP disclosed
CN-112088043-A Compounds for coordination with metals, compositions containing such compounds and methods of catalyzing reactions PPG工业俄亥俄公司 2020-12-15 CN disclosed
CN-106414538-B Composition for producing transparent polythiourethane bodies 科思创德国股份有限公司 2020-02-28 CN disclosed
US-20170121449-A1 COMPOSITION FOR PRODUCING TRANSPARENT POLYTHIOURETHANE BODIES MITSUI CHEMICALS, INC. (JP) 2017-05-04 US disclosed
WO-2017035046-A1 BATCH PROCESS FOR PREPARING MOLDED OPTICAL ARTICLES PPG INDUSTRIES OHIO, INC. (US) 2017-03-02 WO disclosed
US-20170052284-A1 Batch Process for Preparing Molded Optical Articles PPG INDUSTRIES OHIO, INC. 2017-02-23 US disclosed
US-9568644-B2 Polymerization catalyst for polythiourethanes, polymerizable liquid composition and process for the production of organic polythiourethane glass with a high refractive index MITSUI CHEMICALS, INC. (JP) 2017-02-14 US disclosed
US-20170029552-A1 COMPOSITION CONTAINING AROMATIC NITRILES FOR THE PRODUCTION OF TRANSPARENT POLYTHIOURETHANE BODIES COVESTRO DEUTSCHLAND AG (DE) 2017-02-02 US disclosed
EP-2337805-B1 POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE ACOMON AG (CH) 2014-12-17 EP disclosed
US-20140323678-A1 POLYMERIZATION CATALYST FOR POLYTHIOURETHANES, POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC POLYTHIOURETHANE GLASS WITH A HIGH REFRACTIVE INDEX MITSUI CHEMICALS, INC. (JP) 2014-10-30 US disclosed
US-8829147-B2 Polymerizable liquid composition and process for the production of organic glass starting from polymerizable liquid compositions of the polyurethane type ACOMON AG (CH) 2014-09-09 US disclosed
US-20130066034-A1 POLYMERIZATION CATALYST FOR POLYTHIOURETHANES, POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC POLYTHIOURETHANE GLASS WITH A HIGH REFRACTIVE INDEX MITSUI CHEMICALS, INC. (JP) 2013-03-14 US disclosed
US-20110251301-A1 POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE ACOMON AG (CH) 2011-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210079009-A1 Compounds for Coordinating with a Metal, Compositions Containing Such Compounds, and Methods of Catalyzing Reactions EPDR1, BRD2, EED CA2 892/4885CA12 1624/4885CA1 1214/4885
US-11618756-B2 Compounds for coordinating with a metal, compositions containing such compounds, and methods of catalyzing reactions EPDR1, BRD2, EED CA2 892/4885CA12 1624/4885CA1 1214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.